Royal Bank Of Canada Arcturus Therapeutics Holdings Inc. Transaction History

Royal Bank Of Canada

$528 Billion
Q2 2025

A detailed history of Royal Bank Of Canada transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 128,199 shares of ARCT stock, worth $1.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

128,199

Previous 4,697 2629.38%

Holding current value

$1.91 Million

Previous $49,000 3302.04%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$8.91 - $14.41 $1.1 Million - $1.78 Million	123,502 Added 2629.38%	128,199 $1.67 Million
Q1 2025 May 15, 2025	BUY	$10.59 - $20.83 $34,544 - $67,947	3,262 Added 227.32%	4,697 $49,000
Q4 2024 Feb 14, 2025	SELL	$14.82 - $25.48 $28,572 - $49,125	-1,928 Reduced 57.33%	1,435 $24,000
Q3 2024 Nov 14, 2024	SELL	$18.08 - $25.38 $5,207 - $7,309	-288 Reduced 7.89%	3,363 $78,000
Q2 2024 Aug 14, 2024	SELL	$24.35 - $44.39 $105,532 - $192,386	-4,334 Reduced 54.28%	3,651 $88,000
Q1 2024 Nov 05, 2024	BUY	$31.23 - $42.99 $135,350 - $186,318	4,334 Added 118.71%	7,985 $269,000
Q1 2024 May 15, 2024	SELL	$31.23 - $42.99 $114,239 - $157,257	-3,658 Reduced 31.42%	7,985 $269,000
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $71,052 - $132,275	4,012 Added 52.58%	11,643 $367,000
Q3 2023 Nov 14, 2023	BUY	$25.44 - $37.35 $65,075 - $95,541	2,558 Added 50.42%	7,631 $194,000
Q2 2023 Aug 14, 2023	SELL	$23.94 - $32.36 $43,403 - $58,668	-1,813 Reduced 26.33%	5,073 $145,000
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $13,321 - $21,692	905 Added 15.13%	6,886 $165,000
Q4 2022 Feb 14, 2023	BUY	$14.14 - $23.06 $27,346 - $44,598	1,934 Added 47.79%	5,981 $101,000
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $2,257 - $3,828	-173 Reduced 4.1%	4,047 $60,000
Q2 2022 Aug 15, 2022	SELL	$12.26 - $31.17 $22,264 - $56,604	-1,816 Reduced 30.09%	4,220 $67,000
Q1 2022 May 16, 2022	SELL	$17.64 - $39.57 $69,730 - $156,420	-3,953 Reduced 39.57%	6,036 $163,000
Q4 2021 Feb 14, 2022	BUY	$34.2 - $47.56 $87,107 - $121,135	2,547 Added 34.22%	9,989 $370,000
Q3 2021 Nov 15, 2021	BUY	$27.88 - $58.25 $151,862 - $317,287	5,447 Added 273.03%	7,442 $356,000
Q2 2021 Aug 16, 2021	BUY	$25.79 - $42.11 $51,451 - $84,009	1,995 New	1,995 $68,000

Others Institutions Holding ARCT

# of Institutions

169

Shares Held

25.9M

Call Options Held

289K

Put Options Held

109K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $396M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Arcturus Therapeutics Holdings Inc. Transaction History